Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Molecular Dynamics Simulation | 15 | 2024 | 25 | 2.060 |
Why?
|
| Molecular Docking Simulation | 15 | 2024 | 38 | 1.410 |
Why?
|
| Enzyme Inhibitors | 4 | 2023 | 22 | 1.140 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2022 | 11 | 1.090 |
Why?
|
| Anti-Infective Agents | 2 | 2023 | 57 | 0.970 |
Why?
|
| Neoplasms | 8 | 2024 | 147 | 0.960 |
Why?
|
| Protease Inhibitors | 2 | 2021 | 23 | 0.850 |
Why?
|
| Oxidoreductases | 1 | 2023 | 7 | 0.840 |
Why?
|
| Acinetobacter baumannii | 1 | 2023 | 11 | 0.840 |
Why?
|
| Klebsiella pneumoniae | 1 | 2023 | 39 | 0.790 |
Why?
|
| Drug Design | 3 | 2018 | 29 | 0.760 |
Why?
|
| Nucleoproteins | 1 | 2021 | 1 | 0.690 |
Why?
|
| Viral Core Proteins | 1 | 2021 | 10 | 0.690 |
Why?
|
| Protein Binding | 9 | 2021 | 62 | 0.680 |
Why?
|
| Drug Discovery | 6 | 2023 | 23 | 0.670 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2019 | 1 | 0.630 |
Why?
|
| Enzymes | 1 | 2018 | 2 | 0.590 |
Why?
|
| Tubercidin | 1 | 2018 | 1 | 0.570 |
Why?
|
| Zearalenone | 1 | 2018 | 1 | 0.570 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2018 | 1 | 0.570 |
Why?
|
| Humans | 24 | 2024 | 14537 | 0.520 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2015 | 2 | 0.490 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 119 | 0.450 |
Why?
|
| Thymol | 2 | 2024 | 3 | 0.430 |
Why?
|
| Anti-Bacterial Agents | 4 | 2023 | 293 | 0.420 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2024 | 2 | 0.410 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 32 | 0.390 |
Why?
|
| Flavanones | 2 | 2022 | 4 | 0.370 |
Why?
|
| Quorum Sensing | 2 | 2022 | 2 | 0.360 |
Why?
|
| Mutation | 2 | 2021 | 306 | 0.320 |
Why?
|
| Ligands | 2 | 2021 | 33 | 0.320 |
Why?
|
| Thermodynamics | 2 | 2021 | 19 | 0.320 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 2 | 2019 | 2 | 0.300 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2024 | 2 | 0.270 |
Why?
|
| Protein Stability | 3 | 2021 | 4 | 0.260 |
Why?
|
| Hydrogen Bonding | 3 | 2021 | 4 | 0.240 |
Why?
|
| Amino Acid Substitution | 2 | 2021 | 35 | 0.230 |
Why?
|
| Benzoquinones | 1 | 2024 | 1 | 0.220 |
Why?
|
| Artemisinins | 1 | 2024 | 1 | 0.220 |
Why?
|
| Cell Proliferation | 1 | 2024 | 45 | 0.220 |
Why?
|
| Benzofurans | 1 | 2023 | 1 | 0.200 |
Why?
|
| Stilbenes | 1 | 2023 | 1 | 0.200 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 62 | 0.200 |
Why?
|
| Binding Sites | 5 | 2021 | 43 | 0.200 |
Why?
|
| Catalytic Domain | 2 | 2019 | 5 | 0.200 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 9 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2021 | 1 | 0.180 |
Why?
|
| Flavonoids | 1 | 2021 | 7 | 0.180 |
Why?
|
| Fibronectins | 1 | 2021 | 1 | 0.180 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2021 | 19 | 0.170 |
Why?
|
| Pyridines | 1 | 2021 | 11 | 0.170 |
Why?
|
| RNA | 1 | 2021 | 26 | 0.170 |
Why?
|
| Amino Acids | 1 | 2021 | 16 | 0.170 |
Why?
|
| Pyrroles | 1 | 2021 | 12 | 0.170 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2020 | 1 | 0.170 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 44 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2021 | 111 | 0.160 |
Why?
|
| 14-alpha Demethylase Inhibitors | 1 | 2019 | 1 | 0.160 |
Why?
|
| Ergosterol | 1 | 2019 | 2 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1 | 0.160 |
Why?
|
| Candida albicans | 1 | 2019 | 15 | 0.160 |
Why?
|
| Allosteric Site | 1 | 2019 | 2 | 0.160 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 131 | 0.160 |
Why?
|
| Quantum Theory | 1 | 2018 | 1 | 0.150 |
Why?
|
| Heat-Shock Proteins | 1 | 2018 | 2 | 0.150 |
Why?
|
| Genome, Bacterial | 1 | 2015 | 32 | 0.120 |
Why?
|
| Computational Biology | 1 | 2015 | 44 | 0.120 |
Why?
|
| Structure-Activity Relationship | 3 | 2019 | 28 | 0.110 |
Why?
|
| A549 Cells | 2 | 2024 | 4 | 0.100 |
Why?
|
| Protein Conformation | 2 | 2021 | 24 | 0.090 |
Why?
|
| Biofilms | 2 | 2022 | 15 | 0.090 |
Why?
|
| Antifungal Agents | 2 | 2022 | 40 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2020 | 32 | 0.080 |
Why?
|
| Models, Molecular | 2 | 2019 | 84 | 0.080 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2024 | 7 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 23 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 8 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 71 | 0.050 |
Why?
|
| Rutin | 1 | 2024 | 2 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2024 | 6 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2024 | 10 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2024 | 4 | 0.050 |
Why?
|
| Cholic Acid | 1 | 2023 | 1 | 0.050 |
Why?
|
| Serine | 1 | 2023 | 1 | 0.050 |
Why?
|
| Chromobacterium | 1 | 2022 | 1 | 0.050 |
Why?
|
| Imidazoles | 1 | 2022 | 9 | 0.050 |
Why?
|
| Apoptosis | 1 | 2022 | 40 | 0.050 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2022 | 7 | 0.050 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 6 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2021 | 39 | 0.050 |
Why?
|
| Kinetics | 1 | 2021 | 65 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2021 | 11 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 30 | 0.040 |
Why?
|
| Estrogen Antagonists | 1 | 2021 | 1 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 14 | 0.040 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 19 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 139 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2021 | 3 | 0.040 |
Why?
|
| Drug Resistance, Multiple | 1 | 2021 | 6 | 0.040 |
Why?
|
| Genomics | 1 | 2021 | 109 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 33 | 0.040 |
Why?
|
| Sterol 14-Demethylase | 1 | 2019 | 1 | 0.040 |
Why?
|
| Eugenol | 1 | 2019 | 2 | 0.040 |
Why?
|
| Cell Survival | 1 | 2019 | 48 | 0.040 |
Why?
|
| Cysteine | 1 | 2019 | 3 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2019 | 56 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 12 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2018 | 1 | 0.040 |
Why?
|
| Catalysis | 1 | 2018 | 6 | 0.040 |
Why?
|
| Protein Domains | 1 | 2018 | 10 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 198 | 0.040 |
Why?
|
| Computer-Aided Design | 1 | 2018 | 6 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 13 | 0.030 |
Why?
|
| Female | 1 | 2021 | 9103 | 0.020 |
Why?
|